Pentoxifylline Decreases Oxidized Lipid Products in Nonalcoholic Steatohepatitis: New Evidence on the Potential Therapeutic Mechanism

Hepatology - United States
doi 10.1002/hep.25778
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Natural Products: New Hope for Nonalcoholic Steatohepatitis?

Journal of Medicinal Food
MedicineNutritionDietetics
2019English

New Therapeutic Strategies in Nonalcoholic Fatty Liver Disease: A Focus on Promising Drugs for Nonalcoholic Steatohepatitis

Pharmacological Reports
MedicinePharmacology
2020English

Pioglitazone for Advanced Fibrosis in Nonalcoholic Steatohepatitis: New Evidence, New Challenges

Hepatology
MedicineHepatology
2017English

Nonalcoholic Steatohepatitis

English

A New Mechanism of Lipotoxicity: Calcium Channel Blockers as a Treatment for Nonalcoholic Steatohepatitis?

Hepatology
MedicineHepatology
2015English

High-Fat Diet Decreases Activity of the Oxidative Phosphorylation Complexes and Causes Nonalcoholic Steatohepatitis in Mice

DMM Disease Models and Mechanisms
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2014English

Nonalcoholic Fatty Liver Disease: Evidence-Based Management and Early Recognition of Nonalcoholic Steatohepatitis

Journal for Nurse Practitioners
LPNFundamentalsSkillsAdvancedLVNSpecialized Nursing
2019English

Cyclophilin Inhibition as a Potential Treatment for Nonalcoholic Steatohepatitis (NASH)

Expert Opinion on Investigational Drugs
MedicinePharmacology
2019English

New Clinical Score to Diagnose Nonalcoholic Steatohepatitis in Obese Patients

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy